Literature DB >> 20190656

Osteoarthritis and absenteeism costs: evidence from US National Survey Data.

Harry Kotlarz1, Candace L Gunnarsson, Hai Fang, John A Rizzo.   

Abstract

OBJECTIVE: This study seeks to quantify the effects of osteoarthritis on the cost of absenteeism from work.
METHODS: This study performs multivariable analyses to examine the relationships between osteoarthritis and annual cost to employers that is associated with absenteeism. The cost is measured as the probability of absenteeism, days missed from work, and their dollar values, all indirect costs.
RESULTS: Osteoarthritis leads to a significantly higher probability of absenteeism and more days missed from work. Osteoarthritis increases annual per capita absenteeism costs by $469 for female workers and by $520 for male workers. This is equivalent to approximately 3 lost workdays. Aggregate annual absenteeism costs are $10.3 billion (women = $5.5 billion; men = $4.8 billion).
CONCLUSIONS: Aggregate annual absenteeism costs of osteoarthritis are quite substantial as measured by the probability of absenteeism, days missed from work, and their dollar values, compared with other major chronic diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20190656     DOI: 10.1097/JOM.0b013e3181cf00aa

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  28 in total

1.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

2.  Patterns of intra-articular injection use after initiation of treatment in patients with knee osteoarthritis: data from the osteoarthritis initiative.

Authors:  S-H Liu; C E Dubé; J B Driban; T E McAlindon; C B Eaton; K L Lapane
Journal:  Osteoarthritis Cartilage       Date:  2017-06-13       Impact factor: 6.576

3.  Chronic Condition Combinations and Productivity Loss Among Employed Nonelderly Adults (18 to 64 Years).

Authors:  Abdulkarim M Meraya; Usha Sambamoorthi
Journal:  J Occup Environ Med       Date:  2016-10       Impact factor: 2.162

4.  Differential cytotoxicity of corticosteroids on human mesenchymal stem cells.

Authors:  Cody C Wyles; Matthew T Houdek; Saranya P Wyles; Eric R Wagner; Atta Behfar; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2014-09-04       Impact factor: 4.176

5.  Burden of Sickness Absence Due to Chronic Disease in the Dutch Workforce from 2007 to 2011.

Authors:  Ernest M M de Vroome; Kimi Uegaki; Catharina P B van der Ploeg; Daniela B Treutlein; Romy Steenbeek; Marjolein de Weerd; Seth N J van den Bossche
Journal:  J Occup Rehabil       Date:  2015-12

Review 6.  Quality assurance and adverse event management in regenerative medicine for knee osteoarthritis: Current concepts.

Authors:  Maimuna Marenah; Jinjie Li; Ashok Kumar; William Murrell
Journal:  J Clin Orthop Trauma       Date:  2018-09-18

Review 7.  Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain.

Authors:  Vincent Y Ma; Leighton Chan; Kadir J Carruthers
Journal:  Arch Phys Med Rehabil       Date:  2014-01-21       Impact factor: 3.966

Review 8.  The individual and socioeconomic impact of osteoarthritis.

Authors:  David J Hunter; Deborah Schofield; Emily Callander
Journal:  Nat Rev Rheumatol       Date:  2014-03-25       Impact factor: 20.543

9.  The epidemiology and impact of pain in osteoarthritis.

Authors:  T Neogi
Journal:  Osteoarthritis Cartilage       Date:  2013-09       Impact factor: 6.576

10.  The burden of OA-health services and economics.

Authors:  V P Leifer; J N Katz; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2021-05-20       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.